Louisiana 2018 Regular Session

Louisiana House Bill HB821

Introduced
4/3/18  
Introduced
4/3/18  
Refer
4/4/18  
Report Pass
4/11/18  
Engrossed
4/19/18  
Refer
4/23/18  
Refer
4/23/18  
Report Pass
5/2/18  
Report Pass
5/2/18  
Enrolled
5/18/18  
Enrolled
5/18/18  
Chaptered
5/30/18  
Chaptered
5/30/18  

Caption

Provides relative to procedures for HIV testing in cases of possible exposure in certain healthcare settings and emergency situations

Impact

The passage of HB 821 would have a profound impact on the laws governing patient consent and healthcare provider safety protocols. It streamlines the process for necessary testing when healthcare personnel are exposed to potentially infectious bodily fluids, thus facilitating prompt action in protecting the health of those who provide emergency services. By reducing the barriers to testing, this bill aims to ensure that healthcare workers can receive timely information about their exposure status, allowing them to take appropriate post-exposure measures such as prophylaxis and follow-up testing.

Summary

House Bill 821 seeks to amend existing regulations regarding human immunodeficiency virus (HIV) testing in the context of potential exposure for healthcare workers and first responders. The bill allows for testing of bodily fluids without patient consent in specific situations where there is risk of transmission of the virus. It introduces provisions by which hospital infection control committees can test previously drawn blood, or if none is available, order new blood tests in cases of potential exposure to HIV or other infectious agents. This represents a significant shift in how regulations are applied in healthcare settings related to exposure incidents.

Sentiment

Sentiment surrounding the bill appears largely supportive among stakeholders in the healthcare and emergency response fields. Proponents argue that the bill enhances care by prioritizing the safety of healthcare workers and first responders, who routinely face risks in their line of duty. However, there might be concerns from civil liberties advocates about the implications for patient consent and privacy, as the act permits testing without explicit patient approval under certain conditions. This balance between public health needs and individual rights is central to discussions regarding the bill.

Contention

Key points of contention primarily revolve around the issue of patient consent and the confidentiality of medical testing results. While supporters argue that immediate testing is crucial for the health and safety of medical personnel, critics may raise ethical concerns about undermining patient rights. The measures stipulate that results from these tests will remain confidential and not part of the patient’s medical record, aiming to alleviate fears regarding privacy. Nevertheless, the potential for perceived overreach into patient autonomy in emergency situations remains a topic for further discussion.

Companion Bills

No companion bills found.

Previously Filed As

LA HB112

Provides relative to blood and saliva testing of persons who expose certain persons to serious infectious diseases (EN NO IMPACT GF EX See Note)

LA HB275

Prohibits the intentional exposure to HIV

LA HB866

Provides relative to informed consent for medical treatment and creates the La. Medical Disclosure Panel

LA HB436

Provides relative to intentional exposure to HIV

LA HB579

Provides relative to pharmacist authorization to dispense HIV pre-exposure and post-exposure prophylaxis

LA SB239

Provides the methods of obtaining informed consent and creates the Louisiana Medical Disclosure Panel. (gov sig)

LA AB835

Hospital emergency departments: HIV testing.

LA S0269

Repeals the required HIV testing for an individual convicted under chapter 34.1 of title 11 and allows the option for HIV testing for any person convicted under this chapter.

LA S2442

Repeals the required HIV testing for an individual convicted under chapter 34.1 of title 11 and allows the option for HIV testing for any person convicted under this chapter.

LA H5348

Repeals the required HIV testing for an individual convicted under chapter 34.1 of title 11 and allows the option for HIV testing for any person convicted under this chapter.

Similar Bills

No similar bills found.